IndiaTickerGlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Company dossier
GlaxoSmithKline Pharmaceuticals
NSE:GLAXO · ISIN INE159A01016
- Close
- ₹2,626.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
GlaxoSmithKline Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Board Meeting Intimation for Approve And Take On Record The Un-Audited Financial Results For The First Quarter Ended 30Th June 2026.BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - GlaxoSmithKline Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Shareholders meeting - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Trading Window - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Disclosure Under Regulation 30BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Updates - GlaxoSmithKline Pharmaceuticals LimitedNSE · annual report · pdf
Archived filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Letter For Website Link For Annual ReportBSE · annual report · pdf
Archived filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - AGM Notice For 2025-26BSE · exchange filing · pdf
Source filing General Updates - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · zip
Source filing Cessation - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - GlaxoSmithKline Pharmaceuticals LimitedNSE · conference call · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - GlaxoSmithKline Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · investor presentation · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Record Date For Final Dividend 29Th May 2026BSE · corporate action · pdf
Source filing GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing